APA (7th ed.) Citation

H, S., M, G., Y, F., M, L., F, M., C, M., . . . J-B, W. (2026). Population pharmacokinetics of dalbavancin: External validation, model averaging, and implications for precision dosing in prolonged therapy. Antimicrobial agents and chemotherapy, e0066526. https://doi.org/10.1128/aac.00665-26

Chicago Style (17th ed.) Citation

H, Sayadi, et al. "Population Pharmacokinetics of Dalbavancin: External Validation, Model Averaging, and Implications for Precision Dosing in Prolonged Therapy." Antimicrobial Agents and Chemotherapy 2026: e0066526. https://doi.org/10.1128/aac.00665-26.

MLA (9th ed.) Citation

H, Sayadi, et al. "Population Pharmacokinetics of Dalbavancin: External Validation, Model Averaging, and Implications for Precision Dosing in Prolonged Therapy." Antimicrobial Agents and Chemotherapy, 2026, p. e0066526, https://doi.org/10.1128/aac.00665-26.